TenNor Therapeutics (Suzhou) Limited (HKG:6872)
202.00
-1.60 (-0.79%)
Jun 1, 2026, 4:08 PM HKT
HKG:6872 Statistics
Total Valuation
HKG:6872 has a market cap or net worth of HKD 10.45 billion. The enterprise value is 10.28 billion.
| Market Cap | 10.45B |
| Enterprise Value | 10.28B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6872 has 51.75 million shares outstanding.
| Current Share Class | 51.75M |
| Shares Outstanding | 51.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 11.91% |
| Owned by Institutions (%) | 42.20% |
| Float | 25.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 61.06 |
| P/TBV Ratio | 73.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -60.29 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -105.69 |
Financial Position
The company has a current ratio of 5.02, with a Debt / Equity ratio of 0.19.
| Current Ratio | 5.02 |
| Quick Ratio | 4.82 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.33 |
| Interest Coverage | -80.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -41.38% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -63.08% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 432,947 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -132.60M |
| Pretax Income | -170.53M |
| Net Income | -170.53M |
| EBITDA | -132.05M |
| EBIT | -132.60M |
| Earnings Per Share (EPS) | -4.28 |
Balance Sheet
The company has 204.50 million in cash and 31.89 million in debt, with a net cash position of 172.61 million or 3.34 per share.
| Cash & Cash Equivalents | 204.50M |
| Total Debt | 31.89M |
| Net Cash | 172.61M |
| Net Cash Per Share | 3.34 |
| Equity (Book Value) | 171.21M |
| Book Value Per Share | 3.94 |
| Working Capital | 170.49M |
Cash Flow
In the last 12 months, operating cash flow was -97.03 million and capital expenditures -250,382, giving a free cash flow of -97.28 million.
| Operating Cash Flow | -97.03M |
| Capital Expenditures | -250,382 |
| Depreciation & Amortization | 573,371 |
| Net Borrowing | -31.18M |
| Free Cash Flow | -97.28M |
| FCF Per Share | -1.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:6872 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.63% |
| FCF Yield | -0.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |